Mark McCutchen
Geen lopende functies
Profiel
Mark McCutchen worked as Vice President-Business Development at Tissue Repair Co. in 2006.
He also worked as Principal at Chiron Viagene, Inc. and as Chief Financial Officer & Vice President at Selective Genetics, Inc. Additionally, he worked as Vice President-Business Development at Taxus Cardium Pharmaceuticals Group, Inc. Mr. McCutchen holds an MBA degree from the University of Washington and an undergraduate degree from Wheaton College (Massachusetts).
Eerdere bekende functies van Mark McCutchen
| Bedrijven | Functie | Einde |
|---|---|---|
Tissue Repair Co.
 Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Corporate Officer/Principal | 02-08-2006 |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Corporate Officer/Principal | - |
| GENE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Selective Genetics, Inc.
 Selective Genetics, Inc. Medical SpecialtiesHealth Technology Selective Genetics, Inc. developed gene therapeutics and DNA devices for tissue repair and regeneration. The company was founded by Thomas S. Porter in 1998 and was headquartered Encinitas, CA. | Financieel Directeur/CFO | - |
Opleiding van Mark McCutchen
| University of Washington | Masters Business Admin |
| Wheaton College (Massachusetts) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Selective Genetics, Inc.
Selective Genetics, Inc. Medical SpecialtiesHealth Technology Selective Genetics, Inc. developed gene therapeutics and DNA devices for tissue repair and regeneration. The company was founded by Thomas S. Porter in 1998 and was headquartered Encinitas, CA. | Health Technology |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
Chiron Viagene, Inc.
Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Commercial Services |
